Literature DB >> 1701359

Effects of forskolin and analogues on nicotinic receptor-mediated sodium flux, voltage-dependent calcium flux, and voltage-dependent rubidium efflux in pheochromocytoma PC12 cells.

Y Nishizawa1, K B Seamon, J W Daly, R S Aronstam.   

Abstract

1. Forskolin, a naturally occurring diterpene that activates adenylate cyclase, HL706, a water-soluble derivative of forskolin (6 beta-[(piperidino)acetoxy]-7-desacetylforskolin) that is less potent than forskolin in activating adenylate cyclase, and 1,9-dideoxyforskolin, an analogue that does not activate adenylate cyclase, were examined for effects on the nicotinic receptor-mediated 22Na+ flux, a high potassium-induced 45Ca2+ flux through L-type calcium channels, and a high potassium-induced 86Rb+ efflux through a calcium-dependent potassium channels in PC12 cells. 2. Forskolin and analogues at 30 microM completely blocked carbamylcholine-elicited flux of 22Na+ through the nicotinic receptor-gated channel. 1,9-Dideoxyforskolin had an IC50 value of 1.6 microM with forskolin and HL706 being two- to three fold less potent. 3. Forskolin and its analogues appear to be noncompetitive blockers of the neuronal nicotinic receptor-channel complex in PC12 cells, but unlike many noncompetitive blockers, did not markedly enhance desensitization. Instead, forskolin, but not HL706 or 1,9-dideoxyforskolin, slightly antagonized the desensitization evoked by high concentrations of carbamylcholine. N-Ethylcarboxamidoadenosine, an adenosine analogue that elevates cyclic AMP and 8-bromo-cyclic AMP had no effect on desensitization. 4. Forskolin, HL706, and 1,9-dideoxyforskolin in the presence of carbamylcholine inhibited the binding of a noncompetitive blocker, [3H]perhydrohistrionicotoxin, to the muscle-type nicotinic receptor-channel complex in Torpedo electroplax membranes with IC50 values of 20 microM. Forskolin had no effect on [3H]perhydrohistrionicotoxin binding in the absence of carbamylcholine, while HL706 and 1,9-dideoxyforskolin still inhibited binding in the absence of carbamylcholine. 5. Forskolin, but not HL706 or 1,9-dideoxyforskolin had a slight inhibitory effect on the binding of [125I]alpha-bungarotoxin to acetylcholine recognition sites in Torpedo membranes. 1,9-Dideoxyforskolin at 30 microM, but not forskolin or HL706, markedly inhibited depolarization-evoked 45Ca+ flux and 86Rb+ efflux in PC12 cells, suggesting that 1,9-dideoxyforskolin has nonspecific inhibitory effects on a variety of ion channels.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 1701359     DOI: 10.1007/bf00711180

Source DB:  PubMed          Journal:  Cell Mol Neurobiol        ISSN: 0272-4340            Impact factor:   5.046


  41 in total

1.  Opposite actions of forskolin at pre- and postsynaptic sites in rat sympathetic ganglia.

Authors:  H Akagi; Y Kudo
Journal:  Brain Res       Date:  1985-09-23       Impact factor: 3.252

2.  A desensitized form of neuronal acetylcholine receptor detected by 3H-nicotine binding on bovine adrenal chromaffin cells.

Authors:  L S Higgins; D K Berg
Journal:  J Neurosci       Date:  1988-04       Impact factor: 6.167

3.  Properties of the apamin-sensitive Ca2+-activated K+ channel in PC12 pheochromocytoma cells which hyper-produce the apamin receptor.

Authors:  H Schmid-Antomarchi; M Hugues; M Lazdunski
Journal:  J Biol Chem       Date:  1986-07-05       Impact factor: 5.157

4.  Actions of the histrionicotoxins at the ion channel of the nicotinic acetylcholine receptor and at the voltage-sensitive ion channels of muscle membranes.

Authors:  C E Spivak; M A Maleque; A C Oliveira; L M Masukawa; T Tokuyama; J W Daly; E X Albuquerque
Journal:  Mol Pharmacol       Date:  1982-03       Impact factor: 4.436

5.  Agonist-induced regulation of the neuronal nicotinic acetylcholine receptor of PC12 cells.

Authors:  D Robinson; R McGee
Journal:  Mol Pharmacol       Date:  1985-04       Impact factor: 4.436

6.  Histrionicotoxin enhances agonist-induced desensitization of acetylcholine receptor.

Authors:  W Burgermeister; W A Catterall; B Witkop
Journal:  Proc Natl Acad Sci U S A       Date:  1977-12       Impact factor: 11.205

Review 7.  Forskolin: a specific stimulator of adenylyl cyclase or a diterpene with multiple sites of action?

Authors:  A Laurenza; E M Sutkowski; K B Seamon
Journal:  Trends Pharmacol Sci       Date:  1989-11       Impact factor: 14.819

8.  Forskolin alters acetylcholine receptor gating by a mechanism independent of adenylate cyclase activation.

Authors:  M M White
Journal:  Mol Pharmacol       Date:  1988-10       Impact factor: 4.436

9.  Modulation of acetylcholine receptor desensitization by forskolin is independent of cAMP.

Authors:  P K Wagoner; B S Pallotta
Journal:  Science       Date:  1988-06-17       Impact factor: 47.728

10.  Forskolin-induced block of delayed rectifying K+ channels in pancreatic beta-cells is not mediated by cAMP.

Authors:  B J Zünkler; G Trube; T Ohno-Shosaku
Journal:  Pflugers Arch       Date:  1988-06       Impact factor: 3.657

View more
  4 in total

Review 1.  Desensitization of central cholinergic mechanisms and neuroadaptation to nicotine.

Authors:  E L Ochoa; L Li; M G McNamee
Journal:  Mol Neurobiol       Date:  1990 Fall-Winter       Impact factor: 5.590

2.  Functional Fungal Endophytes in Coleus forskohlii Regulate Labdane Diterpene Biosynthesis for Elevated Forskolin Accumulation in Roots.

Authors:  Anthati Mastan; Rkb Bharadwaj; Ramesh Kumar Kushwaha; Chikkarasanahalli Shivegowda Vivek Babu
Journal:  Microb Ecol       Date:  2019-04-17       Impact factor: 4.552

3.  Nicotinic receptor-elicited sodium flux in rat pheochromocytoma PC12 cells: effects of agonists, antagonists, and noncompetitive blockers.

Authors:  J W Daly; Y Nishizawa; M W Edwards; J A Waters; R S Aronstam
Journal:  Neurochem Res       Date:  1991-04       Impact factor: 3.996

4.  Effects of ATP and UTP in pheochromocytoma PC12 cells: evidence for the presence of three P2 receptors, only one of which subserves stimulation of norepinephrine release.

Authors:  B Nikodijevic; Y Sei; Y Shin; J W Daly
Journal:  Cell Mol Neurobiol       Date:  1994-02       Impact factor: 5.046

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.